Active ingredientBesifloxacin HydrochlorideCat. No. P-B058-001CAS 405165-61-9Family · Pharmaceutical analytical standards
Besifloxacin
A fluoroquinolone antibiotic developed in Japan that blocks bacterial DNA gyrase and topoisomerase IV; approved in the United States in 2009 as eye drops for bacterial conjunctivitis. This family brings together the active ingredient and other impurities.
Did you know?It was developed solely for use in the eye and exists neither as tablets nor as an injection; a chlorine atom at position 8 makes it a 'chlorofluoroquinolone'.
Go to the active ingredient →Active ingredientBesifloxacin HydrochlorideCat. No. P-B058-001CAS 405165-61-9
ImpurityBesifloxacin Impurity BCat. No. P-B058-002CAS 101987-89-7
ImpurityBesifloxacin Impurity 1Cat. No. P-B058-003
ImpurityBesifloxacin Impurity CCat. No. P-B058-004
ImpurityBesifloxacin Impurity DCat. No. P-B058-005
ImpurityBesifloxacin Impurity D EnantiomerCat. No. P-B058-006
ImpurityBesifloxacin Impurity ECat. No. P-B058-007
ImpurityBesifloxacin Impurity F HClCat. No. P-B058-008CAS 1613314-38-7
ImpurityBesifloxacin Impurity GCat. No. P-B058-009CAS 124932-43-0
ImpurityDeschloro Besifloxacin Impurity DCat. No. P-B058-010
ImpurityRacemic BesifloxacinCat. No. P-B058-011
ImpurityRacemic Besifloxacin Impurity FCat. No. P-B058-012CAS 1613363-52-2
ImpurityS-Besifloxacin HydrochlorideCat. No. P-B058-013CAS 1398566-42-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.